Drug intelligence / Profile preview

miR-219

Development stage
Preclinical
Lead developer
Henry Ford Health
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intrathecal
01

Overview

miR-219 is a microRNA that serves as a critical regulator of oligodendrocyte differentiation and myelination within the central nervous system. It functions by post-transcriptionally repressing several inhibitory factors of myelination, including Platelet-derived growth factor receptor alpha (PDGFRα) and Forkhead box J3 (Foxj3). In the context of vascular dementia (VaD) and other white matter diseases, miR-219 expression is often reduced, leading to impaired oligodendrocyte progenitor cell (OPC) maturation and subsequent white matter damage. Therapeutic approaches focusing on the augmentation of miR-219 levels, such as through the use of synthetic miR-219 mimics or gene therapy, are being investigated to promote remyelination, restore white matter integrity, and alleviate cognitive and behavioral deficits associated with vascular dementia and multiple sclerosis.

Other names
miRNA-219miRNA219miRNA 219
02

Targets

FOXJ3 (Forkhead box protein J3)PDGFRA (Platelet-derived growth factor receptor alpha)

Beyond the preview

Go deeper on miR-219.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-219.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call